vimarsana.com

Latest Breaking News On - Institutional trading of aurinia pharmaceuticals - Page 1 : vimarsana.com

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 4 6%

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) rose 4.6% during mid-day trading on Monday . The stock traded as high as $5.25 and last traded at $5.24. Approximately 959,196 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 2,388,016 shares. The stock had previously closed at […]

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month Low at $5 50

Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $5.50 and last traded at $5.91, with a volume of 6703556 shares changing hands. The stock had previously closed at $7.97. Aurinia Pharmaceuticals Stock Performance The company […]

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Sees Significant Increase in Short Interest

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 17,010,000 shares, an increase of 21.8% from the August 31st total of 13,960,000 shares. Based on an average daily volume of 2,180,000 shares, the short-interest […]

Aurinia Pharmaceuticals (AUPH) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) in a research note released on Friday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the biotechnology company’s stock. Separately, StockNews.com assumed coverage on shares of Aurinia Pharmaceuticals in a report on Thursday, August 17th. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.